Capvizr
THE DEAL, AT A GLANCE

Epsilon Health

2/4 reviewed
Epsilon Health source image associated with the reported financing
Epsilon Health

Epsilon Health sells health products, including laxatives, wound-care treatments and honey-based cough syrup.

Epsilon Health raised $20M Series A, announced 2026-09-09
Source-provided image · View source ↗
01What it doesEpsilon Health sells health products, including laxatives, wound-care treatments and honey-based cough syrup.Source-grounded · automated review · Explore ↗

Checked 2026-10-08 · Review due 2026-10-15

Read supporting source ↗
WWW.EFFECOL.GR Μακρογόλη 3350, οσμωτικό υπακτικό…
02Who is involvedBacked by the PitchBook PlatformFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedEpsilon Health raised $20M Series A, announced 2026-09-09From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersIts sales network reaches pharmacies and distributors across the Balkans.Source-grounded · automated review · Explore ↗

Checked 2026-10-08 · Review due 2026-10-15

Read supporting source ↗
Covers the whole Balkans territory…
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗

Epsilon Health · Financing Record

Explore source-linked visual explanations for Epsilon Health. Unsupported claims are withheld while source review continues.

Record 12181 · Recorded date: 2026-09-09

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime